✓ checked
trust me, bro:
here is the receipt.
the claim
The hepatitis B virus can become active again later in life in people who have had hepatitis B.
the verdict
SUPPORTED
the evidence backs this
Recorded sources
12 sources for · 0 against
Is it true that the hepatitis B virus can become active again later in life in people who have had hepatitis B?
Yes. The hepatitis B virus can persist in the body even after apparent recovery or loss of surface antigens, creating a risk of viral reactivation later in life under conditions of immunosuppression or specific medical treatments.
Verdict: SUPPORTED · 12 sources for, 0 against · Last checked
The analysis
The retrieved papers consistently demonstrate that individuals with past or occult hepatitis B virus infection retain replication-competent viral DNA (such as cccDNA) within hepatocytes, which can reactivate later in life when triggered by immunosuppressive therapy, chemotherapy, corticosteroids, or changes in antiviral management.
Evidence for · 12
Discusses occult hepatitis B virus infection and how it may reactivate in patients undergoing immunosuppressive therapy or chemotherapy.
Get citation
Raimondo, G., Filomia, R., & Maimone, S. (2014). Therapy of Occult Hepatitis B Virus Infection and Prevention of Reactivation. doi.org. https://doi.org/10.1159/000360943
See more details
More for · 11
Notes that HBsAg-negative patients with past HBV infection remain at risk for HBV reactivation and liver-related complications.
Get citation
Jung, J. & Nguyen, M. H. (2022). Liver-Related Mortality in Hepatitis B Virus Core Antibody+/Hepatitis B Virus Surface Antigen− Patients: Occult Hepatitis B Virus, Hepatitis B Virus Reactivation, and Hepatocellular Carcinoma Development. doi.org. https://doi.org/10.14309/ajg.0000000000002030
Highlights that management of HBV infection must account for the risk of viral replication or reactivation during systemic therapies.
Get citation
G, A., D, C., I, T., F, M., J, F., J, A., & P, F. (2026). Psoriasis and Chronic Viral Infections (HIV, HBV, and HCV): Therapeutic Approach and Safety.. doi.org. https://doi.org/10.3390/medicina62091796
Indicates that coinfection with HBV increases the risk of liver injury, noting HBV reactivation as a specific mechanism.
Get citation
XJ, L., N, Z., Q, Z., R, C., & G, Y. (2026). HBV/HCV coinfection and anti-tuberculosis drug-induced liver injury: from risk assessment and exploration of mechanisms to preventive considerations.. doi.org. https://doi.org/10.1007/s10096-026-05686-z
Explains that treatment-induced liver injury in HBV-related conditions can arise from direct causes including HBV reactivation.
Get citation
Y, T., J, Z., Y, W., Y, M., X, L., & E, C. (2026). From mechanisms to practice: risk management and multidisciplinary decision-making for systemic treatment-related liver injury in HBV-associated hepatocellular carcinoma.. doi.org. https://doi.org/10.3389/fphar.2026.1871275
Desribes how occult hepatitis B infection persists and can lead to viral reactivation during periods of immunosuppression.
Get citation
F, W., L, W., Z, X., Z, O., Y, W., H, Y., J, F., J, S., Y, C., & K, L. (2026). The immunoecology of occult hepatitis B virus infection: genetic remodeling and the immune-mediated microcosm.. doi.org. https://doi.org/10.3389/fimmu.2026.1899891
States that functionally cured chronic hepatitis B represents an occult HBV infection state that retains the potential for viral reactivation.
Get citation
F, L., X, Z., X, D., X, Y., Y, L., J, Z., & Y, Y. (2026). Functionally cured chronic hepatitis B: A cure-related occult HBV infection state.. doi.org. https://doi.org/10.1002/mlf2.70102
Evaluates the occurrence and safety profiles regarding HBV reactivation in cancer patients receiving systemic therapies.
Get citation
M, B., A, S., A, N., DA, K., A, A., M, A., A, A., B, S., & H, M. (2026). Safety of Immune Checkpoint Inhibitors in Hepatitis B Virus-Positive Cancer Patients: A Multicenter Retrospective Cohort Study.. doi.org. https://doi.org/10.3390/curroncol33080469
Reports that patients with current or past HBV infection receiving corticosteroid therapy are at increased risk of hepatitis B reactivation.
Get citation
H, Ö. Ç., Ö, A., B, K., B, D. K., ZB, R., & A, A. Y. (2026). Risk of hepatitis B reactivation in COVID-19 patients receiving corticosteroid therapy: A retrospective cohort study.. doi.org. https://doi.org/10.1097/md.0000000000050373
Examines how occult hepatitis B infection can lead to viral reactivation following switches or discontinuation of antiretroviral therapy.
Get citation
G, L., A, S., M, P., & P, B. (2026). Occult hepatitis B and risk of reactivation following switch to non-hepatitis B virus-active antiretroviral therapy in people with HIV.. doi.org. https://doi.org/10.1097/qad.0000000000004511
Evaluates isolated anti-HBc as an indicator of occult HBV infection which confers reactivation risk under immunosuppression.
Get citation
H, Z. (2026). Hepatitis B in Isolated Anti-HBc Carriers: Predictors of Detectable HBV DNA and Implications for Risk-Stratified Screening.. doi.org. https://doi.org/10.3390/v18080899
Reports on patients with resolved or occult hepatitis B who remain at risk of viral reactivation following immunosuppressive therapies.
Get citation
BTH, N., HP, T., NT, U. H., TN, M., TN, T., QK, T., & DL, N. (2026). Identification of occult hepatitis B infection despite high anti-HBs in a hemodialysis patient during pretransplant evaluation.. doi.org. https://doi.org/10.1016/j.idcr.2026.e02768
What does the evidence say?
The retrieved papers consistently demonstrate that individuals with past or occult hepatitis B virus infection retain replication-competent viral DNA (such as cccDNA) within hepatocytes, which can reactivate later in life when triggered by immunosuppressive therapy, chemotherapy, corticosteroids, or changes in antiviral management.
Receipt History
Anyone with this link can read the claim and its public receipt, including any
personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check
or guarantee a response time.
Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.
This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work
Terms · Privacy · How verdicts work